country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-P11903

Copy Link Print Information

dTBP-3

dTBP-3 is a fully D-configured polypeptide competitive inhibitor that targets TIGIT. dTBP-3 can competitively occupy the binding interface between TIGIT and its ligand PVR, block TIGIT-mediated immunosuppressive signals, and reverse the immune exhaustion of NK cells and CD8⁺ T cells. dTBP-3 possesses anti-proteolytic activity and tumor tissue penetration ability, and can also enhance the tumor penetration capacity and cellular internalization efficiency of nanocarriers. dTBP-3 can be used in studies related to liver cancer, triple-negative breast cancer and non-small cell lung cancer.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

分子式: C₇₀H₉₃N₂₁O₁₆
分子量:1484.62

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

カスタムペプチド

dTBP-3 構造式

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

体外実験

OthersAnti-cancer

Others

dTBP-3 can be completely released from DTBP-3NP-siANRIL within 6 h, while it remains tightly bound in the absence of GSH; in addition, dTBP-3-conjugated nanoparticles are taken up by Hep3B cells in a concentration-dependent manner, which inhibits Hep3B cell proliferation and induces apoptosis^[1].
dTBP-3 conjugated with PLLD forms DTBP-PLLD, which can be liberated from PR-T@PLLD in a pH-dependent pattern and displays elevated release efficiency under acidic lysosomal and tumor microenvironment conditions^[2].
dTBP-3-derived tracer [¹⁸F]TTDP binds to purified human TIGIT protein with a K_D value of 40.14 nM, confirming its high-affinity targeting to human TIGIT^[3].

Anti-cancer

dTBP-3 modification on PR-T@PLLD nanocarriers boosts cellular internalization and strengthens the cytotoxicity of co-loaded PTX and RC, with an IC₅₀ value of 9.57 μg/mL at 48 h; it also facilitates efficient lysosomal escape in anti-PD-1 resistant 4T1 triple-negative breast cancer cells, and yields superior cellular uptake together with reduced lysosomal retention relative to unmodified nanocarriers^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Anti-cancerInnate ImmunityAdaptive ImmunityApoptosisCytokines & ChemokinesOthers

Anti-cancer

Innate Immunity

Adaptive Immunity

Apoptosis

dTBP-3 inhibits hepatocellular carcinoma by blocking the TIGIT/PVR pathway to enhance tumor immunity, increase the proportions of NK cells and T cells, slow tumor growth, and prolong the survival of tumor-bearing mice^[1].

Anti-cancer

Adaptive Immunity

Innate Immunity

Cytokines & Chemokines

Apoptosis

dTBP-3 (40 mg/kg, administered via tail vein base injection once every 3 days for a total of 5 doses) can enhance the in vivo anti-tumor effect against anti-PD-1-resistant triple-negative breast cancer via the PR-T@PLLD nanoplatform, strengthen the activity of CD8⁺ cytotoxic T cells, remodel the tumor immune microenvironment, and promote the secretion of pro-inflammatory cytokines; it can also induce the formation of immune memory in the body and effectively inhibit lung metastasis of triple-negative breast cancer^[2].

Others

dTBP-3 can be used to synthesize the intravenous tracer [¹⁸F]TTDP. This probe specifically targets TIGIT-positive tumor-infiltrating lymphocytes in mice and humans, shows significantly higher tumor uptake than all control groups, can quantitatively reflect the intratumoral TIGIT expression level, predict the intervention effect of combined immunotherapy, and shares the same urinary metabolic clearance pathway in rhesus monkeys as in mice^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

化学情報

分子量 1484.62
分子式 C₇₀H₉₃N₂₁O₁₆
配列

Gly-Gly-D-{Tyr-Thr-Phe-His-Trp-His-Arg-Leu-Asn-Pro}
シーケンスの短縮

GGytfhwhrlnp
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Wang T, et al. TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy. Journal of drug targeting. 2021 Aug;29(7):783-791.

[2]. Wang J, et al. Tumor targeting dendritic nanocarrier with immunogenic cell death inducing and TIGIT blockade for synergistic chemo-immunotherapy against TNBC. Journal of nanobiotechnology. 2025 Dec 07;23(1):759.

[3]. Wang J, et al. Development and characterisation of [F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates. European journal of nuclear medicine and molecular imaging. 2025 Jan;52(2):416-426.

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- 体外実験
- 体内実験
化学情報
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

dTBP-3

生物活性

製品説明

体外実験

体内実験

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

dTBP-3 関連分類

HY-P11903 関連分類

Bioz

Keywords

最近チェックした製品